Some of the most controversial discussions in health today involve whether certain anti-parasitic medications could play a role in integrative cancer care.

On today's show, we explore an emerging and debated area of research looking at three repurposed compounds being studied for potential cancer-support applications.

We break down how drugs like Ivermectin and Mebendazole are being investigated for possible effects on cancer cell structure, metabolism, and programmed cell death pathways.

You'll also hear why fenbendazole has gained attention in integrative circles, and what the current research actually does and does not show.

Most importantly, we discuss why these compounds are not stand-alone treatments, how they may fit into a broader integrative approach, and why medical supervision and proper context are essential.

So join me on today's Cabral Concept 3749 as we explore the science, controversy, and integrative perspective behind repurposed anti-parasitic research in cancer. Enjoy the show and let me know your thoughts!